Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ferdeghini

Showing results (61-70 of 167) with videos related to

Pageof 17
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 1, 1984
Comparison of plasma and urinary methods for the direct measurement of the thyroxine to 3,5,3' - triiodothyronine conversion rate in manR Bianchi, A Pilo, G Mariani, et al.
Acta Diabetologica Latina|April 1, 1990
Inappropriate growth-hormone (GH) response to thyrotropin-releasing hormone (TRH) occurs infrequently in well-regulated diabetes mellitusO Giampietro, M Ferdeghini, R Miccoli, et al.
Kidney International. Supplement|February 7, 1998
Tumor-associated trypsin inhibitor (TATI) and renal functionG Tramonti, M Ferdeghini, C Donadio, et al.
The Journal of Nuclear Medicine and Allied Sciences|January 1, 1989
The serum concentrations of TAG-72 antigen measured with CA 72-4 IRMA in patients with ovarian carcinoma. Preliminary dataA Gadducci, M Ferdeghini, T Ceccarini, et al.
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)|January 1, 1991
CA 195: a new monoclonal antibody-defined Lea blood group-related tumor marker in patients with epithelial ovarian cancerA Gadducci, M Ferdeghini, C Prontera, et al.
Clinical Chemistry|July 1, 1980
Radioimmunoassay of free cortisol with antiserum-coated tubes and 125I-labeled cortisolM G Del Chicca, A Clerico, M Ferdeghini, et al.
Journal of Endocrinological Investigation|May 16, 2006
Long-term quiescence of ectopic Cushing's syndrome caused by pulmonary neuroendocrine tumor (typical carcinoid) and tumorlets: spontaneous remission or therapeutic effect of bromocriptine?G Francia, M V Davì, E Montresor, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1996
Serum tumour-associated trypsin inhibitor (TATI) and renal functionG Tramonti, C Donadio, M Ferdeghini, et al.
Gynecologic Oncology|February 1, 1992
The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosisA Gadducci, M Ferdeghini, C Prontera, et al.
Renal Failure|August 14, 2001
Relationship between renal function and blood level of chromogranin AG Tramonti, M Ferdeghini, C Annichiarico, et al.
Pageof 17

Showing results (61-70 of 167) with videos related to

Sort By:
Pageof 17
The Journal of Clinical Endocrinology and Metabolism|June 1, 1984
Comparison of plasma and urinary methods for the direct measurement of the thyroxine to 3,5,3' - triiodothyronine conversion rate in manR Bianchi, A Pilo, G Mariani, et al.
Acta Diabetologica Latina|April 1, 1990
Inappropriate growth-hormone (GH) response to thyrotropin-releasing hormone (TRH) occurs infrequently in well-regulated diabetes mellitusO Giampietro, M Ferdeghini, R Miccoli, et al.
Kidney International. Supplement|February 7, 1998
Tumor-associated trypsin inhibitor (TATI) and renal functionG Tramonti, M Ferdeghini, C Donadio, et al.
The Journal of Nuclear Medicine and Allied Sciences|January 1, 1989
The serum concentrations of TAG-72 antigen measured with CA 72-4 IRMA in patients with ovarian carcinoma. Preliminary dataA Gadducci, M Ferdeghini, T Ceccarini, et al.
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)|January 1, 1991
CA 195: a new monoclonal antibody-defined Lea blood group-related tumor marker in patients with epithelial ovarian cancerA Gadducci, M Ferdeghini, C Prontera, et al.
Clinical Chemistry|July 1, 1980
Radioimmunoassay of free cortisol with antiserum-coated tubes and 125I-labeled cortisolM G Del Chicca, A Clerico, M Ferdeghini, et al.
Journal of Endocrinological Investigation|May 16, 2006
Long-term quiescence of ectopic Cushing's syndrome caused by pulmonary neuroendocrine tumor (typical carcinoid) and tumorlets: spontaneous remission or therapeutic effect of bromocriptine?G Francia, M V Davì, E Montresor, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1996
Serum tumour-associated trypsin inhibitor (TATI) and renal functionG Tramonti, C Donadio, M Ferdeghini, et al.
Gynecologic Oncology|February 1, 1992
The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosisA Gadducci, M Ferdeghini, C Prontera, et al.
Renal Failure|August 14, 2001
Relationship between renal function and blood level of chromogranin AG Tramonti, M Ferdeghini, C Annichiarico, et al.
Pageof 17